Procept BioRobotics Corp

NASDAQ:PRCT 4:00:00 PM EDT

72.66

-1.65 (-2.22%)

: $72.13 -0.53 (-0.73%)

Market Cap (Intraday)	3.69B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$53.31 Million
Adjusted EPS	-$0.49

See more estimates

10-Day MA	$76.20
50-Day MA	$73.16
200-Day MA	$59.32

See more pivots

Procept BioRobotics Corp Stock, NASDAQ:PRCT

150 Baytech Drive, Suite 170, San Jose, California 95134

United States of America

Phone: +1.650.232.7200

Number of Employees: 626

http://www.procept-biorobotics.com

Description

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.